Barbexaclone (Maliasin) is a salt compound of phenobarbital and levopropylhexedrine.[2] It was introduced in 1983. It has been reported to be as effective as phenobarbital but better tolerated; however, as of 2004, these "promising results"[3] had not yet been confirmed nor denied in controlled trials.
Combination of | |
---|---|
Phenobarbital | Barbiturate |
Levopropylhexedrine | Sympathomimetic |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
CAS Number |
|
PubChem CID |
|
DrugBank |
|
ChemSpider |
|
UNII |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.022.278 |
(what is this?) (verify) |
100 mg of barbexaclone is equivalent to 60 mg of phenobarbital.[2]